Inventor · disambiguated record
Charles Hart
Also filed as: HART CHARLES · HART CHARLES P · HART CHARLES PRARAY
5 granted patents·11 pending applications·232 citations·filing 1992–2024
80Inventor score
Files withTHRESHOLD PHARMACEUTICALS INC6CURD KAREN3MOLECULAR TEMPLATES INC3AFFYMAX INC1AFFYMAX TECH NV1
Top patents by PatentIndex Score
16 records- 0190US6107059APeptide library and screening methodAFFYMAX TECH NV·Filed 1992·Granted Aug 22, 2000·140 cites·8 claims
- 0285US6410245B1Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactionsAFFYMAX INC·Filed 1998·Granted Jun 25, 2002·83 cites·17 claims
- 0379US8946275B2Treatment of cancer using hypoxia activated prodrugsKROLL STEWART·Filed 2009·Granted Feb 3, 2015·8 cites·18 claims
- 0475US2025295869A1Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancerIMMUNOGENESIS INC·Filed 2024·Application pending·0 cites
- 0565US9254299B2Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancerTHRESHOLD PHARMACEUTICALS INC·Filed 2012·Granted Feb 9, 2016·1 cites·13 claims
- 0661US2019060275A1Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancerMOLECULAR TEMPLATES INC·Filed 2018·Application pending·0 cites
- 0753US2014010805A1Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancerCURD KAREN·Filed 2011·Application pending·0 cites
- 0850US2015258125A1Treatment of cancer using hypoxia activated prodrugsTHRESHOLD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0946US2014171389A1Methods for treating cancerCURD KAREN·Filed 2012·Application pending·0 cites
- 1045US10760130B2Predictive biomarker for hypoxia-activated prodrug therapyMOLECULAR TEMPLATES INC·Filed 2015·Granted Sep 1, 2020·0 cites·9 claims
- 1145US2015005262A1Hypoxia activated prodrugs and mtor inhibitors for treating cancerTHRESHOLD PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 1243US2021369746A1Administration of hypoxia activated prodrugs in combination with immune modulatory agents for treating cancerMOLECULAR TEMPLATES INC·Filed 2017·Application pending·0 cites
- 1341US2016296538A1Predictive and response biomarker for th-302 anti-cancer therapyTHRESHOLD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1440US2016158253A1Treatment of pancreatic cancer with a combination of a hypoxia-activated prodrug and a taxaneTHRESHOLD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1539US2015005264A1Predictive biomarker for hypoxia-activated prodrug therapyTHRESHOLD PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1636US2013296273A1Treatment of blood cancerCURD KAREN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles Hart files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →